Venous Thromboembolism Global Clinical Trials Review, H1, 2012
Venous Thromboembolism Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionVenous Thromboembolism
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Venous Thromboembolism
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bayer AG
Clinical Trial Overview of Bayer AG
Sanofi
Clinical Trial Overview of Sanofi
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Clinical Trial Overview of L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
ThromboGenics NV
Clinical Trial Overview of ThromboGenics NV
Daiichi Sankyo, Inc.
Clinical Trial Overview of Daiichi Sankyo, Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
LEO Pharma A/S
Clinical Trial Overview of LEO Pharma A/S
Bayer Inc.
Clinical Trial Overview of Bayer Inc.
MEDRAD Interventional/POSSIS
Clinical Trial Overview of MEDRAD Interventional/POSSIS
ARYx Therapeutics, Inc.
Clinical Trial Overview of ARYx Therapeutics, Inc.
Medco Health Solutions Inc.
Clinical Trial Overview of Medco Health Solutions Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Utrecht University
Clinical Trial Overview of Utrecht University
Ottawa Hospital Research Institute
Clinical Trial Overview of Ottawa Hospital Research Institute
University of Calgary
Clinical Trial Overview of University of Calgary
Centre Hospitalier Universitaire de Saint Etienne
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
The University of Utah
Clinical Trial Overview of The University of Utah
Brigham and Women's Hospital
Clinical Trial Overview of Brigham and Women's Hospital
Università degli Studi dell'Insubria
Clinical Trial Overview of Università degli Studi dell'Insubria
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
Ontario Clinical Oncology Group
Clinical Trial Overview of Ontario Clinical Oncology Group
Stanford University
Clinical Trial Overview of Stanford University
University of Padua
Clinical Trial Overview of University of Padua
St. Joseph's Healthcare Hamilton
Clinical Trial Overview of St. Joseph's Healthcare Hamilton
St. Orsola Hospital
Clinical Trial Overview of St. Orsola Hospital
University Hospital, Brest
Clinical Trial Overview of University Hospital, Brest
Slotervaart Hospital
Clinical Trial Overview of Slotervaart Hospital
HOPITAL LARIBOISIERE
Clinical Trial Overview of HOPITAL LARIBOISIERE
University of Missouri
Clinical Trial Overview of University of Missouri
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2012*
Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2012*
Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Venous Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A.L Clinica Pesquisa e Desenvolvimento Ltda., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by MEDRAD Interventional/POSSIS, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ARYx Therapeutics, Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medco Health Solutions Inc., 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Università degli Studi dell'Insubria, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Padua, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Slotervaart Hospital, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by HOPITAL LARIBOISIERE, 2012*
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2012*
LIST OF FIGURES
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2012*
Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2012*
Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top